Nomura Asset Management Co. Ltd. trimmed its position in shares of CME Group Inc (NASDAQ:CME) by 53.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 120,862 shares of the financial services provider’s stock after selling 141,051 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in CME Group were worth $20,898,000 at the end of the most recent quarter.
Several other institutional investors have also recently modified their holdings of the company. Legal & General Group Plc increased its stake in shares of CME Group by 2.6% during the first quarter. Legal & General Group Plc now owns 2,185,853 shares of the financial services provider’s stock worth $378,251,000 after acquiring an additional 54,775 shares during the period. Deutsche Bank AG grew its position in CME Group by 6.9% during the first quarter. Deutsche Bank AG now owns 980,064 shares of the financial services provider’s stock worth $169,463,000 after buying an additional 63,497 shares during the period. AIA Investment Management Private Ltd grew its position in CME Group by 17.3% during the first quarter. AIA Investment Management Private Ltd now owns 623 shares of the financial services provider’s stock worth $108,000 after buying an additional 92 shares during the period. M&T Bank Corp grew its position in CME Group by 8.2% during the first quarter. M&T Bank Corp now owns 86,623 shares of the financial services provider’s stock worth $14,977,000 after buying an additional 6,574 shares during the period. Finally, MML Investors Services LLC grew its position in CME Group by 16.2% during the first quarter. MML Investors Services LLC now owns 6,633 shares of the financial services provider’s stock worth $1,147,000 after buying an additional 925 shares during the period. Institutional investors and hedge funds own 84.93% of the company’s stock.
In other CME Group news, COO Julie Holzrichter sold 3,011 shares of the stock in a transaction that occurred on Monday, April 6th. The shares were sold at an average price of $180.00, for a total transaction of $541,980.00. Following the transaction, the chief operating officer now owns 41,091 shares of the company’s stock, valued at $7,396,380. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director William R. Shepard purchased 771 shares of the business’s stock in a transaction on Tuesday, June 2nd. The shares were bought at an average cost of $178.10 per share, for a total transaction of $137,315.10. Following the purchase, the director now owns 771 shares of the company’s stock, valued at $137,315.10. The disclosure for this purchase can be found here. Company insiders own 1.20% of the company’s stock.
CME has been the topic of several recent analyst reports. Citigroup upped their target price on shares of CME Group from $200.00 to $215.00 and gave the stock a “buy” rating in a research report on Monday, April 20th. Raymond James raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $194.00 price target on the stock in a report on Monday, March 30th. UBS Group upped their price target on shares of CME Group from $222.00 to $225.00 and gave the company a “buy” rating in a report on Thursday, April 30th. Rosenblatt Securities reduced their price target on shares of CME Group from $153.00 to $152.00 and set a “sell” rating on the stock in a report on Wednesday, June 3rd. Finally, Bank of America reduced their price target on shares of CME Group from $216.00 to $168.00 and set a “neutral” rating on the stock in a report on Monday, March 23rd. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $193.33.
Shares of CME traded down $11.45 on Thursday, hitting $177.25. 1,535,674 shares of the stock traded hands, compared to its average volume of 2,181,481. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $68.90 billion, a P/E ratio of 27.56, a P/E/G ratio of 4.74 and a beta of 0.32. The stock’s 50 day moving average is $181.50 and its two-hundred day moving average is $194.54. CME Group Inc has a 1 year low of $131.80 and a 1 year high of $225.36.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, April 29th. The financial services provider reported $2.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.23 by $0.10. The business had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.48 billion. CME Group had a net margin of 45.79% and a return on equity of 10.15%. The company’s quarterly revenue was up 29.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.62 earnings per share. Research analysts forecast that CME Group Inc will post 7.71 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Wednesday, June 10th will be paid a dividend of $0.85 per share. This represents a $3.40 dividend on an annualized basis and a yield of 1.92%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s dividend payout ratio is currently 50.00%.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Further Reading: Straddles
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.